With approximately a quarter of all clinical trials and up to 40% of drugs in the development pipeline focused on oncology, each day seems to bring innovations in research that result in new therapies for cancer patients.

Our client collaborations have been enhancing clinical practice and treatment of neurological and psychiatric disorders for decades, positively impacting human health, public policy and the testing of innovative therapeutic solutions.

Our Phase I-IV clinical trial research services can advance your neuroscience research program, from protocol development to regulatory submissions and publications, and we offer particular expertise in Alzheimer’s disease, multiple sclerosis, epilepsy, traumatic brain injury, stroke, major depression

Faster and higher quality clinical trial documents

Accelerated Drafting With 
AI-Powered Precision

Extract meaningful insights from vast clinical trial datasets more easily than ever. Eliminate the need for complex statistical tools or coding knowledge. Enable users to create custom datasets and visualizations using simple English queries. Through VERA’s conversational AI-powered interface, simplify data access, enhance decision-making, and streamline collaboration across research teams, clinical sites, and sponsors.

Real-time & Purpose-built

GlobalTrace is purpose-built to track every step of the specimen’s journey in real-time when sample integrity and chain of custody are critical. The information recorded includes, specimen attributes, linkage to clinical data, current & previous locations, shipment workflow, issue management.

Modernizing DCT With AI

Veridix is modernizing DCT by incorporating AI and automation into the core processes used to conduct remote and hybrid clinical trials. Many aspects of DCTs benefit from modernization including: